Abstract
This paper discusses the purpose and methodology of the economic evaluation techniques of cost-benefit (CBA) and cost-effectiveness analysis (CEA). It then reviews applications of the techniques in 22 evaluative studies, published between 1978 and mid-1987, of clinical pharmacy services in organized health care settings. Major conclusions are that CBA and CEA have not been extensively adopted in the evaluation of clinical pharmacy services and that the studies which have been done are lacking in rigor.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Pharmaceutical Marketing & Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
